IL6 and colorectal carcinoma: In particular, we found that IL-6/CD81, IL-6/Cyclin D1, and IL-6/Cyclin D1/CD81 as triplets were significantly more abundant in CRC recurrent cases compared to samples with no relapse (AUC: 0.85, 0.85, and 0.83, respectively).